Neuburgh Advisers’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$329K Buy
36,853
+1,325
+4% +$11.6K 0.01% 567
2019
Q2
$304K Hold
35,528
0.01% 589
2019
Q1
$270K Hold
35,528
0.01% 607
2018
Q4
$294K Buy
35,528
+1,010
+3% +$9.66K 0.01% 539
2018
Q3
$342K Buy
34,518
+5,112
+17% +$52.9K 0.01% 586
2018
Q2
$288K Hold
29,406
0.01% 558
2018
Q1
$273K Hold
29,406
0.01% 565
2017
Q4
$280K Buy
29,406
+4,732
+19% +$45.2K 0.01% 570
2017
Q3
$255K Buy
24,674
+2,714
+12% +$25.1K 0.01% 544
2017
Q2
$182K Buy
21,960
+9,465
+76% +$71K 0.01% 597
2017
Q1
$90K Sell
12,495
-2,208
-15% -$16K ﹤0.01% 642
2016
Q4
$105K Buy
+14,703
New +$102K ﹤0.01% 578

Other funds holding SEM

Neuburgh Advisers's SEM Position: Q3 2019 in Review

Neuburgh Advisers increased its Select Medical (SEM) stake by 3.7% in Q3 2019, buying an estimated $11.6K and bringing the position to 36,853 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #567.

Neuburgh Advisers first reported a position in SEM in Q4 2016 and has held it in 12 quarters since. The position peaked at $342K in Q3 2018. 187 funds tracked by Wall St. Rank hold SEM as of Q3 2019.

  • Neuburgh Advisers held 36,853 shares of Select Medical worth $329K as of Q3 2019.
  • Neuburgh Advisers bought 1,325 Select Medical shares in Q3 2019, an estimated $11.6K.
  • Select Medical made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #567 holding.
  • Neuburgh Advisers first reported a position in Select Medical in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Select Medical position peaked at $342K in Q3 2018.
  • 187 funds tracked by Wall St. Rank held Select Medical as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.